Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, September 24, 2019
Bayer, Brigham and Women's Hospital, and Massachusetts General Hospital announced the launch of a joint lab to research new drug candidates to treat chronic lung diseases.
read more
Monday, September 23, 2019
Immutep will receive a milestone payment from GSK of £4 million related to the first patient being dosed in GSK’s Phase II clinical trial evaluating GSK2831781 for ulcerative colitis.
read more
Monday, September 23, 2019
Sygnature Discovery has announced its US office has moved.
read more
Monday, September 23, 2019
Pii has announced the commercial supply of Fulvestrant Injection 250mg/5ml drug product, which was recently approved by the FDA.
read more
Monday, September 23, 2019
Hikma Pharmaceuticals has launched a new prefilled syringe capability in the US through its affiliate, Hikma Pharmaceuticals USA Inc.
read more
Monday, September 23, 2019
Varcode has appointed Joseph Battoe as the company’s new president and CEO.
read more
Friday, September 20, 2019
PCI Pharma Services (PCI) has opened its newly expanded Clinical Center of Excellence in Rockford, IL.
read more
Friday, September 20, 2019
Cryoport announced the launch of its Advanced Therapy Shipper™ product line for the regenerative medicine market.
read more
Friday, September 20, 2019
The FDA has classified 3P facilities as acceptable for the manufacture of the target molecule, and appropriate for its commercialization in the US market, once the product is authorized.
read more
Friday, September 20, 2019
Hovione announced details of its planned Phase 3 development program for the treatment of moderate to severe inflammatory rosacea.
read more
Thursday, September 19, 2019
PMRS has filed a petition asking the U.S. Court of Appeals for the District of Columbia Circuit to overturn the FDA's refusal to approve a new opioid capsule intended to deter abuse.
read more
Thursday, September 19, 2019
PPD is expanding its bioanalytical laboratory in Richmond, Virginia, improving its ability to provide capabilities to meet biopharmaceutical clients’ increasing research needs.
read more
Thursday, September 19, 2019
Caribou has granted Oxford Nanopore a worldwide, non-exclusive license under foundational CRISPR-Cas9 intellectual property controlled by Caribou for nanopore sequencing.
read more
Wednesday, September 18, 2019
One Drop announced $40 million in Series B financing, led by pharmaceutical company, Bayer.
read more
Wednesday, September 18, 2019
Darmerica is voluntarily recalling two lots, DR4654A and DL4654A, of Quinacrine Dihydrochloride, bulk API powder packaged in Amber HDPE Bottles to the consumer level.
read more